An antibody cocktail called REGN-COV2 designed to treat and prevent coronavirus infection is being tested at FOMAT Medical Research in Oxnard. FOMAT is launching two clinical trials for COVID-19 treatment, the disease caused by the SARS-COV-2, on Thursday, reported CBS Los…
‘Looking Very Promising’: COVID-19 Prevention, Treatment Clinical Trials Begin In Oxnard
FOMAT Medical Research is testing an antibody cocktail, which has been gaining attention nationally as a possible way to treat and prevent the infection. An important treatment is happening right here in Oxnard California, a Clinical Research Company is working on…
Biopharma Update on the Novel Coronavirus: June 8
FDA Actions Reissued EUAs: The FDA reissued EUAs revising which types of respirators can be decontaminated for reuse. Availability and Capability of Non-Invasive Monitoring Devices: The FDA issued new guidance that expands the availability and capability of non-invasive monitoring devices. This guidance replaces…
Merck, IAVI Work to Develop COVID-19 Vaccine
Merck (NYSE:MRK) and IAVI announced today that they are collaborating to develop an investigational vaccine against SARS-CoV-2 for preventing COVID-19. The vaccine candidate is slated to use the recombinant vesicular stomatitis virus (rVSV) technology used as the basis for Merck’s Ervebo Ebola Zaire virus…
Phlow Lands $354M Government Contract for COVID-19 Medications
Phlow announced today that it received $354 million in U.S. government funding to manufacture essential medicines at risk of shortage, including those involved in the COVID-19 pandemic response. This Covid-19 medications will be a helping aid to succeed against this terrible…
How is coronavirus vaccine development going in the U.S.?
Researchers in Pittsburgh and Boston are moving forward with research into two separate coronavirus vaccine programs against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. The work of the University of Pittsburgh School of Medicine researchers is detailed in a paper published recently…